Yao, Song <br/><br/>
Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2010 
 - 6169-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-10-0281  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Algorithms<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Cyclophosphamide--adverse effects<br/>Cytochrome P-450 CYP2B6<br/>Cytochrome P-450 CYP3A--genetics<br/>Disease-Free Survival<br/>Female<br/>Glutathione S-Transferase pi--genetics<br/>Glutathione Transferase--genetics<br/>Humans<br/>Inactivation, Metabolic--genetics<br/>Metabolic Networks and Pathways--genetics<br/>Middle Aged<br/>North America<br/>Oxidoreductases, N-Demethylating--genetics<br/>Polymorphism, Genetic--physiology